Chris Freeman - 03 Aug 2021 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Commercial Officer
Signature
/s/ John Saia, as attorney-in-fact for Chris Freeman
Issuer symbol
GH
Transactions as of
03 Aug 2021
Transactions value $
$0
Form type
4
Filing time
05 Aug 2021, 17:18:14 UTC
Previous filing
08 Jul 2021
Next filing
17 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Award $0 +19.5K $0.00 19.5K 03 Aug 2021 COMMON STOCK 19.5K $0.00 Direct F1, F2
transaction GH STOCK OPTION (RIGHT TO BUY) Award $0 +39K $0.00 39K 03 Aug 2021 COMMON STOCK 39K $110.49 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit vests as to 25% of the shares subject to such award on June 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of June 15, 2022, during the three-year period thereafter.
F2 Not applicable to Restricted Stock Units.
F3 The stock option vests as to 25% of the shares subject to such award on June 8, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of June 8, 2022, during the three-year period thereafter.